YOLFTbeta
30

Guangzhou Boji Medical and Biotechnological Co Ltd

300404 · SHE · Healthcare / Biotechnology

11.21CNY-0.66 (-5.56%)

Price History

Full chart

Market Stats

Previous Close11.87
Open11.80
Day Range11.14 – 11.90
52-Week Range8.15 – 17.99
Volume25.89M
Market Cap5.68B
P/E (TTM)105.21
Forward P/E0.00
EPS0.14
Dividend Yield0.09%
Beta0.28
50-Day Avg12.69
200-Day Avg10.71

About

Boji Medical Technology Co.,Ltd. provides professional contract research services for research and development, and production of drugs and medical devices to pharmaceutical enterprises in China and internationally. The company offers pre-clinical research, clinical research, and other consulting services. It also provides clinical drug production, pilot test scale-up, process verification batch production, and drug registration and approval services. In addition, it engages in the screening, evaluation, verification, and trading of technological achievements formed in the process of new drug research and development. The company was formerly known as Guangzhou Boji Medical & Biotechnological Co., Ltd. and changed its name to Boji Medical Technology Co.,Ltd. in September 2021. Boji Medical Technology Co.,Ltd. was founded in 1998 is headquartered in Guangzhou, China.

Company Details

  • SectorHealthcare
  • IndustryBiotechnology
  • CEOMr. Tingchun Wang M.D., Ph.D.
  • Employees1.20K
  • HeadquartersBuilding A, Vanke Cloud Plaza, Guangzhou, China, 510000, China
  • Websitehttps://www.bojicro.com

Leadership

  • Mr. Tingchun Wang M.D., Ph.D.Founder, Chairman & GM · b. 1965
  • Ms. Xiu Qing OuDeputy GM, CFO & Director · b. 1982
  • Ms. Fangqun WeiDeputy GM & Secretary of the Board · b. 1986
  • Mr. Shaobo WenDeputy General Manager · b. 1983
  • Ms. Lian ZuoDeputy General Manager · b. 1968
  • Mr. Zhanpeng ChenAccounting Supervisor

Financials

Income Statement

Currency: CNY2012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue125.59M136.41M143.28M126.63M72.15M130.75M172.04M224.06M260.47M324.20M423.68M555.83M742.02M868.64M
Growth (%)-+8.62%+5.03%-11.62%-43.02%+81.22%+31.58%+30.24%+16.25%+24.47%+30.68%+31.19%+33.50%+17.06%
Cost of Revenue61.80M70.21M69.16M63.83M37.05M94.94M93.59M128.78M146.66M184.08M262.97M370.54M516.63M633.03M
Gross Profit---62.79M35.11M35.82M78.45M95.29M113.81M140.12M160.71M185.29M225.39M235.62M
Gross Margin---49.59%48.66%27.39%45.60%42.53%43.70%43.22%37.93%33.34%30.38%27.12%
Operating Expense---38.83M35.06M48.22M56.77M74.12M75.99M85.58M125.96M152.27M184.68M175.56M
Operating Income37.59M39.77M42.96M23.97M43.10K-12.41M21.69M21.17M37.82M54.53M34.75M33.02M40.71M60.05M
Operating Margin29.93%29.15%29.98%18.93%0.06%-9.49%12.61%9.45%14.52%16.82%8.20%5.94%5.49%6.91%
EBITDA------25.64M25.39M27.28M44.25M66.38M46.77M42.42M48.83M59.87M
EBITDA Margin------19.61%14.76%12.17%16.99%20.47%11.04%7.63%6.58%6.89%
Net Income33.30M35.16M37.96M25.66M2.09M-24.49M7.40M6.59M16.99M38.88M27.67M24.34M28.78M30.49M
Net Income Margin26.52%25.78%26.50%20.27%2.89%-18.73%4.30%2.94%6.52%11.99%6.53%4.38%3.88%3.51%
R&D--7.13M10.42M5.95M10.42M13.48M18.28M26.44M27.65M43.68M54.97M62.59M57.50M
R&D as % of Total Revenue--4.98%8.23%8.25%7.97%7.84%8.16%10.15%8.53%10.31%9.89%8.44%6.62%
Interest Expense000000593.87K383.31K1.48M1.41M704.29K1.53M3.19M1.68M
Interest Expense % of Total Revenue0.00%0.00%0.00%0.00%0.00%0.00%0.35%0.17%0.57%0.43%0.17%0.28%0.43%0.19%

Balance Sheet

Currency: CNY2012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets233.40M293.64M310.26M520.15M518.85M574.72M606.02M633.08M749.63M1.14B1.27B1.43B1.45B1.63B
Total Liabilities63.04M88.12M91.78M87.47M89.01M160.37M182.31M177.00M264.64M291.83M376.71M448.82M448.84M569.88M
Total Equity170.36M205.52M218.48M432.68M428.10M404.23M412.55M422.65M444.24M813.99M855.05M955.85M973.38M1.03B
Cash97.56M138.11M117.61M133.01M105.15M133.24M55.24M57.35M146.38M384.52M306.93M397.16M270.13M326.21M

Cash Flow

Currency: CNY2012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow41.40M43.48M25.69M1.93M-34.24M26.22M27.06M85.87K97.07M30.10M28.14M35.95M26.78M87.01M
Investing Cash Flow----174.37M9.97M-31.52M-96.48M-9.60M-29.19M-93.52M----
Financing Cash Flow---189.25M-4.60M38.06M-12.88M11.31M22.86M302.40M----
Capital Expenditure14.03M2.93M22.60M13.94M78.17M62.47M38.03M29.00M31.42M53.99M117.73M62.20M29.35M18.71M
Free Cash Flow------36.25M-10.97M-28.92M65.64M-23.89M-89.59M-26.24M-2.57M68.30M
Dividends Paid--25.00M6.67M6.67M2.39M2.39M2.39M3.23M1.20M6.84M8.04M7.58M5.92M
FCF to OCF------138.27%-40.56%-33675.78%67.63%-79.35%-318.39%-73.00%-9.61%78.50%
Dividend Paid to FCF------6.60%-21.79%-8.27%4.91%-5.03%-7.64%-30.63%-294.82%8.67%

Earnings

Report DateAug 19, 2015Oct 26, 2015Feb 29, 2016Apr 25, 2016Aug 27, 2016Oct 27, 2016Feb 27, 2017Apr 26, 2017Aug 28, 2017Oct 27, 2017Dec 31, 2017Apr 26, 2018Aug 28, 2018Oct 25, 2018Dec 31, 2018Apr 26, 2019Jun 30, 2019Sep 30, 2019Dec 31, 2019Apr 24, 2020Aug 28, 2020Oct 28, 2020Dec 31, 2020Apr 27, 2021Jun 30, 2021Sep 30, 2021Dec 31, 2021Mar 31, 2022Jun 30, 2022Sep 30, 2022Dec 31, 2022Apr 25, 2023Aug 25, 2023Oct 26, 2023Dec 31, 2023Apr 24, 2024Aug 26, 2024Sep 30, 2024Dec 31, 2024Apr 25, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026
EPS Estimate--------------------------------------------
EPS Actual0.030.020.030.00-0.010.01-0.00-0.010.01-0.01-0.070.020.000.000.000.000.000.010.00-0.030.080.03-0.010.030.020.050.010.030.010.020.020.030.020.010.000.040.040.03-0.040.010.030.020.020.04
Surprise--------------------------------------------
TimingPre-marketAfter-hoursAfter-hoursAfter-hoursPre-marketPre-marketPre-marketPre-marketPre-marketAfter-hours-Pre-marketPre-marketAfter-hours-Pre-market---------------Pre-marketPre-marketAfter-hours-Pre-marketPre-market--Pre-market----

Key Statistics & Ratios

Market Cap5.68B
Enterprise Value5.49B
Trailing P/E105.21
Forward P/E0.00
Price / Sales5.91
Price / Book5.40
EPS0.14
Book Value2.84
Revenue (TTM)961.34M
Gross Profit (TTM)238.84M
EBITDA52.52M
Profit Margin5.42%
Operating Margin2.30%
Return on Equity4.94%
Return on Assets1.03%
Shares Outstanding385.75M
Shares Float243.80M
Beta0.28
Dividend Yield0.09%
Dividend Rate0.01
Payout Ratio15.83%

Dividends

20261×
0.01Jun 17, 2026
20251×
0.01Jul 15, 2025
20241×
0.01May 27, 2024
20231×
0.01Jul 11, 2023
20221×
0.02Jun 2, 2022
20201×
0.01Jun 12, 2020
20191×
0.01Jun 10, 2019
20161×
0.02Jun 7, 2016

Stock Splits

  • Jun 2, 20221.4:1
  • Jun 12, 20201.3:1
  • Jun 10, 20191.3:1
  • Oct 20, 201520:10